Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection - Wikidata - wikimedia - TriplyDB

Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection

Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection

http://www.wikidata.org/entity/Q35608012

about

Neurotropic Enterovirus Infections in the Central Nervous System Expansion of amphibian intronless interferons revises the paradigm for interferon evolution and functional diversity Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses Type I Interferons Induce T Regulatory 1 Responses and Restrict Humoral Immunity during Experimental Malaria Type I interferon suppresses virus-specific B cell responses by modulating CD8(+) T cell differentiation Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation.Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS Type I interferons in viral control and immune regulation Beyond autophagy: New roles for ULK1 in immune signaling and interferon responses.HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways To Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes.IFN-ε protects primary macrophages against HIV infection PTPN22 contributes to exhaustion of T lymphocytes during chronic viral infection.Type I Interferon Impairs Specific Antibody Responses Early during Establishment of LCMV Infection.Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection.Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.Protozoan Parasites and Type I IFNs.Type I interferons regulate susceptibility to inflammation-induced preterm birth.Effects of type 1 diabetes-associated IFIH1 polymorphisms on MDA5 function and expression.Peginterferon α-2a for the treatment of HIV infection.A hot spot on interferon α/β receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling.Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes.Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.The Roles of Type I Interferon in Bacterial Infection.Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.Human pDCs display sex-specific differences in type I interferon subtypes and interferon α/β receptor expression.IRF9 Prevents CD8+ T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus Infection.Extrinsic Protein Tyrosine Phosphatase Non-Receptor 22 Signals Contribute to CD8 T Cell Exhaustion and Promote Persistence of Chronic Lymphocytic Choriomeningitis Virus Infection.Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection.Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection.Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling Virologic and Immunologic Characteristics in Mature Ducks with Acute Duck Hepatitis A Virus 1 Infection.Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.Genetic Control of Lyme Arthritis by Borrelia burgdorferi Arthritis-Associated Locus 1 Is Dependent on Localized Differential Production of IFN-β and Requires Upregulation of Myostatin.Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies.

P2860

Q26776541-421A2D5F-4387-4256-B605-564A4E02FFF3 Q27469006-1C26762F-5165-4B9B-AA7D-6BB9A753A836 Q28079141-2226C158-5D42-4ED2-AE65-14B6FB34D4D1 Q28554673-D98AE669-4266-46F4-80B6-41B3AEEDE95B Q30827049-0AF375A6-81F7-4ACD-8216-D4E7ADAD942D Q35903800-BA61324E-C836-45EA-B4B7-F46A36B9E97C Q36358084-754DC62E-6267-427F-97BD-611F30AD8F23 Q36646579-40066BE4-FE8C-4DCF-BD7D-C6452D358556 Q36767643-FE0040A7-E4BB-4B07-9F6D-D8BBA12E3EA1 Q36984702-C9FF87DA-0045-45C6-97DC-1DB6F55F44E8 Q37002574-5C7528EF-AE21-4B2C-B7D7-4886E9158EF1 Q37469163-4607AB00-FFEA-4156-8D20-457E8BAA65DA Q37469344-F0A1E63C-52CA-4E9F-BDFB-C7FA7C2146F6 Q37471226-55333AC2-9744-42FF-9146-19EBE9398AFE Q37513066-3987DCA2-CD2C-4E2D-B1D0-2728FE259F62 Q37559660-41FE9087-2252-409C-A20C-EF44E3036825 Q37592659-1224B9F2-7464-4407-900A-5F90AEF65F6E Q37677428-FDE93B56-3E0E-4065-B23E-5A49379C35DB Q38589318-0CBC2142-20BD-42D4-BF7A-B84CE4E7463C Q38669306-ECD471E0-A3B8-4E96-A5FB-4865A77E3914 Q38712385-CF550274-C687-4AAA-B549-21BF8C52E11A Q38715891-15700CB3-B227-4FE3-8D54-6465912F1344 Q38727885-9043BA99-91A0-469D-A063-7FA9C689E64A Q38777005-8A5BD37C-288F-434D-842B-F6949BD76A21 Q38826175-F0F15BF3-A1A2-406B-8C1A-E26729AEAF6D Q38860235-BA246342-008C-4E85-8E24-86B760D5A2C0 Q38953303-1A479B40-5776-405D-A039-187CB4D722EA Q39149760-C90F85C5-F8E2-4EF0-A2B2-7D08AAD70CE3 Q40055021-42132856-E5F5-4F7E-A421-FD2003A3C072 Q40106843-F0E05459-FBBF-4026-8EEE-08132CB53788 Q40160105-292FF0F0-E7ED-4208-B8D3-EDE19536C71C Q40532348-1E353281-49CC-4D48-BCCF-76EF5F2A18F2 Q40705563-2354D91D-A539-41DE-B6FB-E5ECC6D65DCC Q42291845-89B7CC40-514B-4C17-ABB4-D0CC316EB3CC Q45323854-B8C1C8F0-ADDF-45C9-BB8E-5F7AFE3D0D15 Q47102123-B4AFBCFE-67B3-4A60-916C-9F7C3D3C9FF8 Q47684846-459E3141-F608-4158-BE66-16F375E6028F Q52723506-224810DA-3559-4C95-916E-BF1E34E9A6B9 Q54269208-E67F4996-01A5-4393-9D74-2DFF42558960 Q55260301-58797E62-F7B9-4559-8217-CBC3A45D3EC9

P2860

Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection

http://www.wikidata.org/entity/Q35608012

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Blockade of interferon Beta, b ...... ols persistent viral infection

@ast

Blockade of interferon Beta, b ...... ols persistent viral infection

@en

type

label

Blockade of interferon Beta, b ...... ols persistent viral infection

@ast

Blockade of interferon Beta, b ...... ols persistent viral infection

@en

prefLabel

Blockade of interferon Beta, b ...... ols persistent viral infection

@ast

Blockade of interferon Beta, b ...... ols persistent viral infection

@en

P1433

Q35608012-E10923A7-789D-4AE0-8767-5214C583E401

P1476

Q35608012-6D2D3420-CC0D-401A-BA0D-187F5EB50E5C

P2093

Q35608012-07B6F648-D687-40D1-962B-E2FEB566E317

Q35608012-354F5C26-CC12-4EF6-8795-9A1732E50618

Q35608012-3E9404F1-E9DF-4D48-BAA0-448EB1372B90

Q35608012-67638B43-2225-4AEC-9E59-D5E04D01448A

Q35608012-6850556F-0AFD-417E-9BCB-9AE436E8FB75

Q35608012-BA6D1D79-5F44-407D-9054-E317BCB139E1

Q35608012-C6C112A6-5CD1-4E2A-8154-79890FCE83C9

Q35608012-EF3FDCE3-A429-498E-B47E-E73002E06B01

Q35608012-F62C128F-4BB8-46B5-A135-C4184DED645D

P2860

Q35608012-013E088E-7043-4F5F-A194-28477E7207E8

Q35608012-03370872-13ED-457C-B22A-29378D439903

Q35608012-07FEAD0B-DE95-4A7D-BB6E-FE4D04DEC345

Q35608012-0AE55AD4-CB5B-4519-98A0-6F31F5EF783B

Q35608012-18F79636-57C2-4A31-BAA1-52EED40B10E9

Q35608012-25A064C9-7B6E-4915-B85D-49658DD3ACF9

Q35608012-2AF05D83-0A7F-4C39-BB8D-72F654A3C4F0

Q35608012-2C199449-B8F7-443E-8B85-CF048ADFFA8A

Q35608012-37EB034D-94D4-4D90-B231-0F98A8B1176A

Q35608012-3F92BD50-8427-4704-8317-74949519F0E6

P304

Q35608012-7FEF26D0-533C-4503-B6F3-D2AB296E73AA

P31

Q35608012-927F1E57-ED23-40AF-817F-0FA406615D90

P356

Q35608012-97BBC7EC-A95F-415B-B77A-6F1CB5A8C6AD

P433

Q35608012-B97FCBA9-D8F7-4181-B96B-736AAEEBDB01

P478

Q35608012-DD934354-4110-4C21-9FF3-716D844F508C

P577

Q35608012-28908782-57FE-4F72-82B1-7626DC2B9422

P5875

Q35608012-7261775F-1842-4090-B883-8C88FFDF1B04

P698

Q35608012-F37FE726-C03F-47EF-86FE-D8B20B1287C9

P932

Q35608012-19CC1399-0F77-482E-B57F-CB36A88A1366

P356

J.CHOM.2015.04.005

P1433

Cell Host & Microbe

P1476

Blockade of interferon Beta, b ...... ols persistent viral infection

@en

P2093

Andrew M Lee

http://www.w3.org/2001/XMLSchema#string

Brian M Sullivan

http://www.w3.org/2001/XMLSchema#string

Cherie T Ng

http://www.w3.org/2001/XMLSchema#string

John R Teijaro

http://www.w3.org/2001/XMLSchema#string

Kathleen C F Sheehan

http://www.w3.org/2001/XMLSchema#string

Megan Welch

http://www.w3.org/2001/XMLSchema#string

Michael B A Oldstone

http://www.w3.org/2001/XMLSchema#string

Robert D Schreiber

http://www.w3.org/2001/XMLSchema#string

Stephanie Rice

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-10 determines viral clearance or persistence in vivo

Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons

Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.

Restoring function in exhausted CD8 T cells during chronic viral infection

Type I interferon is a therapeutic target for virus-induced lethal vascular damage.

Pathogenic potential of interferon αβ in acute influenza infection

Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.

Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques.

Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.

Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression.

P304

653-661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CHOM.2015.04.005

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276358905

http://www.w3.org/2001/XMLSchema#string

P698

25974304

http://www.w3.org/2001/XMLSchema#string

P932

4432251

http://www.w3.org/2001/XMLSchema#string